慢性肝病中的剪切波分散:从物理原理到临床有用性
Matteo Garcovich1, Mattia Paratore1, Maria Elena Ainora1
1Medicina Interna e Gastroenterologia, CEMAD Digestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
Journal of personalized medicine
|June 28, 2023
概括
新的超声波弹性成像技术可以评估肝脏粘度,为肝脏疾病如死体炎症提供生物力学见解. 这种多参数超声波方法对肝病管理中的临床应用有前途.
科学领域:
- 医疗成像医学成像
- 生物物理学的生物物理.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 超声波 (美国) 影像在治疗肝脏疾病方面发挥着至关重要的作用.
- 在B模式成像,对比度增强US (CEUS) 和US弹性学方面的进步导致了多参数超声波 (MP-US).
研究的目的:
- 通过超声波的剪切波分散来评估肝脏粘度的可行性和临床应用.
- 探索剪切波分散作为肝脏病理的生物力学标记物的潜力.
主要方法:
- 综述了超声波弹性图学的最新进展,特别是剪切波分散.
- 关于肝脏粘度测量的动物和人类研究初步发现的分析.
- 探索集成到超声波设备中的软件,以评估剪切波分散和肝脏粘度.
主要成果:
- 剪波分散使剪波分散斜率的评估成为可能,可能反映组织粘度.
- 肝脏粘度分析可以提供与肝脏疾病相关的生物力学信息,例如死体炎症.
- 初步研究表明,肝脏粘度评估的可行性和潜在的临床应用.
结论:
- 多参数超声波,包括切削波分散用于肝脏粘度,代表了肝脏疾病管理的新方法.
- 剪波分散超声波显示出非侵入性评估肝脏生物力学和病理状态的潜力.
- 需要进一步的研究,以充分确定超声波中肝脏粘度评估的临床实用性.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
146
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
146
Diseases of the Liver and Gallbladder
674
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
64
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
64
Liver Physiology
679
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
679
Hepatic Drug Clearance: Effect of Protein Binding
253
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
253
Hepatic Drug Clearance: Role of Transporters
87
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
87


